DUBLIN--(BUSINESS WIRE)--Research and Markets has announced the addition of the "Global Point of Care Diagnostics Market Analysis & Trends - Industry Forecast to 2025" report to their offering.
The Global Point of Care Diagnostics Market is poised to grow at a CAGR of around 8.5% over the next decade to reach approximately $48.2 billion by 2025.
This industry report analyzes the global markets for Point of Care Diagnostics across all the given segments on global as well as regional levels presented in the research scope. It presents historical market data for 2013, 2014 revenue estimations are presented for 2015 and forecasts from 2016 till 2025.
The study focuses on market trends, leading players, supply chain trends, technological innovations, key developments, and future strategies. The report provides comprehensive market assessment across the major geographies such as North America, Europe, Asia Pacific, Middle East, Latin America and Rest of the world.
The study presents detailed market analysis with inputs derived from industry professionals across the value chain. A special focus has been made on 23 countries such as U.S., Canada, Mexico, U.K., Germany, Spain, France, Italy, China, Brazil, Saudi Arabia, South Africa, etc.
The market size is calculated based on the revenue generated through sales from all the given segments and sub segments in the research scope. The market sizing analysis includes both top-down and bottom-up approaches for data validation and accuracy measures.
Key Topics Covered:
1 Market Outline
2 Executive Summary
3 Market Overview
4 Point of Care Diagnostics Market, By Product
5 Point of Care Diagnostics Market, By End User
6 Point of Care Diagnostics Market, By Technology
7 Point of Care Diagnostics Market, By Prescription
8 Point of Care Diagnostics Market, By Geography
9 Leading Companies
- Abaxis, Inc.
- Abbott Laboratories
- Bayer HealthCare
- Beckman Coulter, Inc.
- Becton, Dickinson, & Co.
- Church & Dwight Co., Inc.
- Danaher Corp.
- Johnson and Johnson
- Nipro Diagnostics, Inc.
- Nova Biomedical
- Orasure Technologies
- Phamatech, Inc.
- Roche Holding Ltd.
- Siemens HealthCare
- Spectral Diagnostics
- Trinity Biotech Plc
For more information visit http://www.researchandmarkets.com/research/3cjlsp/global_point_of